Logo image
Using imaging as a biomarker for asthma
Journal article   Open access   Peer reviewed

Using imaging as a biomarker for asthma

Abhaya Trivedi, Chase Hall, Eric A Hoffman, Jason C Woods, David S Gierada and Mario Castro
Journal of allergy and clinical immunology, Vol.139(1), pp.1-10
01/2017
DOI: 10.1016/j.jaci.2016.11.009
PMCID: PMC5224930
PMID: 28065276
url
https://doi.org/10.1016/j.jaci.2016.11.009View
Published (Version of record) Open Access

Abstract

There have been significant advancements in the various imaging techniques being used for the evaluation of asthmatic patients, both from a clinical and research perspective. Imaging characteristics can be used to identify specific asthmatic phenotypes and provide a more detailed understanding of endotypes contributing to the pathophysiology of the disease. Computed tomography, magnetic resonance imaging, and positron emission tomography can be used to assess pulmonary structure and function. It has been shown that specific airway and lung density measurements using computed tomography correlate with clinical parameters, including severity of disease and pathology, but also provide unique phenotypes. Hyperpolarized 129Xe and 3He are gases used as contrast media for magnetic resonance imaging that provide measurement of distal lung ventilation reflecting small-airway disease. Positron emission tomography can be useful to identify and target lung inflammation in asthmatic patients. Furthermore, imaging techniques can serve as a potential biomarker and be used to assess response to therapies, including newer biological treatments and bronchial thermoplasty.
biomarker MRI Imaging PET chest CT

Details

Logo image